| 1 |
Xiang M, Gu Y, Zhao F, et al (2020). Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep, 23, 615-9./
|
|
| 2 |
Panis C, Herrera A, Victorino V, Aranome A, Cecchini R (2013). Screening of circulating TGF-$\beta$ levels and its clinicopathological significance in human breast cancer. Anticancer Res, 33, 737-42./
|
|
| 3 |
Jung KW, Won YJ, Kong HJ, et al (2013). Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat, 45, 1-14./
|
|
| 4 |
Shafie NH, Mohd Esa NM, Ithnin H, et al (2013). Prophylactic Inositol Hexaphosphate (IP6) inhibits colon cancer through involvement of Wnt/$\beta$-catenin and COX-2 pathway. BioMed Res Int, 2013, 681027./
|
|
| 5 |
Pandurangan AK (2013). Potential targets for the prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev, 14, 3007-11./
|
|
| 6 |
Pandurangan AK, Anandasadagopan SK, Dharmalingam P, et al (2013c). Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through Nrf2 signaling. Toxicol Mech and Methods, [Epub Ahead of Print]./
|
|
| 7 |
Pandurangan AK, Ganapasam S (2013a). Luteolin modulates cellular thiols on azoxymenthane-induced colon carcinogenesis. Asian J Exp Biol Sci, 4, 245-50./
|
|
| 8 |
Pandurangan AK, Dharmalingam P, Ananda Sadagopan SK, et al (2013). Luteolin induces growth arrest in colon cancer cells through involvement of Wnt/$\beta$-catenin/GSK-3$\beta$. J Environ Pathol Toxicol Oncol, 32, 131-9./
|
|
| 9 |
Pandurangan AK, Dharmalingam P, Anandasadagopan SK, Ganapasam S (2013a). Inhibitory effect of Luteolin on the status of membrane bound ATPases against Azoxymethane-induced colorectal cancer. J Chem Pharm Res, 5, 123-127./
|
|
| 10 |
Pandurangan AK, Ganapsam S (2013b). Luteolin induces apoptosis in azoxymethane-induced colon carcinogenesis through involvement of Bcl-2, Bax, and Caspase-3. J Chem Pharm Res, 5, 143-8./
|
|